Publication: Effect of vitamin A on intestinal mucosal injury in pediatric patients receiving hematopoietic stem cell transplantation and chemotherapy: A quasai-randomized trial
Issued Date
2020-10-02
Resource Type
ISSN
17560500
Other identifier(s)
2-s2.0-85092384378
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
BMC Research Notes. Vol.13, No.1 (2020)
Suggested Citation
Ploy Pattanakitsakul, Nalinee Chongviriyaphan, Samart Pakakasama, Nopporn Apiwattanakul Effect of vitamin A on intestinal mucosal injury in pediatric patients receiving hematopoietic stem cell transplantation and chemotherapy: A quasai-randomized trial. BMC Research Notes. Vol.13, No.1 (2020). doi:10.1186/s13104-020-05307-8 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/59870
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Effect of vitamin A on intestinal mucosal injury in pediatric patients receiving hematopoietic stem cell transplantation and chemotherapy: A quasai-randomized trial
Other Contributor(s)
Abstract
© 2020 The Author(s). Objective: Vitamin A is involved in maintenance of gut mucosal integrity and normal immune function. However, it is unclear whether these functions of vitamin A have any beneficial effects in patients undergoing hematopoietic stem cell transplantation (HSCT). In this study, we aimed to examine the potential protective effect of vitamin A supplementation on gastrointestinal (GI) mucosal integrity in HSCT recipients using plasma citrulline as a surrogate marker of intestinal integrity. Results: We performed a quasi-randomized trial in 30 pediatric patients undergoing HSCT. Half (n = 15) of the patients received a single high dose of vitamin A (200,000 IU) before the conditioning regimen was given, and half (n = 15) did not. Clinical data of patients who developed post-Transplant complications were recorded for 60 days after HSCT. There were no significant differences in mean plasma citrulline levels on day 7 after HSCT between the treatment and control groups (5.8 vs. 5.9 μmol/L, respectively). The incidence of mucositis and other complications were not different between the two groups within 60 days of HSCT. Vitamin A supplementation prior to HSCT in pediatric patients had no clinical benefit in protecting GI mucosal integrity.